Report Detail

Pharma & Healthcare Global Finasteride Market Growth 2019-2024

  • RnM3146066
  • |
  • 19 March, 2019
  • |
  • Global
  • |
  • 165 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

Finasteride is a prescription drug in tablet form.

According to this study, over the next five years the Finasteride market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Finasteride business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Finasteride market by product type, application, key manufacturers and key regions and countries.

This study considers the Finasteride value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
1mg Tablet
5mg Tablet
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Medical Uses
Application II

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck
Actavis
Sandoz
Teva Pharmaceuticals
Cipla
RelonChem
Dr. Reddy
Accord Pharmaceuticals
Henan Topfond
Zhejiang CONBA Pharmaceutical
Shandong Renhetang Pharmaceutical
Guangdong Eashu Pharmacetical

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Finasteride consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Finasteride market by identifying its various subsegments.
Focuses on the key global Finasteride manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Finasteride with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Finasteride submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Finasteride Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Finasteride Consumption 2014-2024
        • 2.1.2 Finasteride Consumption CAGR by Region
      • 2.2 Finasteride Segment by Type
        • 2.2.1 1mg Tablet
        • 2.2.2 5mg Tablet
      • 2.3 Finasteride Consumption by Type
        • 2.3.1 Global Finasteride Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Finasteride Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Finasteride Sale Price by Type (2014-2019)
      • 2.4 Finasteride Segment by Application
        • 2.4.1 Medical Uses
        • 2.4.2 Application II
      • 2.5 Finasteride Consumption by Application
        • 2.5.1 Global Finasteride Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Finasteride Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Finasteride Sale Price by Application (2014-2019)

      3 Global Finasteride by Players

      • 3.1 Global Finasteride Sales Market Share by Players
        • 3.1.1 Global Finasteride Sales by Players (2017-2019)
        • 3.1.2 Global Finasteride Sales Market Share by Players (2017-2019)
      • 3.2 Global Finasteride Revenue Market Share by Players
        • 3.2.1 Global Finasteride Revenue by Players (2017-2019)
        • 3.2.2 Global Finasteride Revenue Market Share by Players (2017-2019)
      • 3.3 Global Finasteride Sale Price by Players
      • 3.4 Global Finasteride Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Finasteride Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Finasteride Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Finasteride by Regions

      • 4.1 Finasteride by Regions
        • 4.1.1 Global Finasteride Consumption by Regions
        • 4.1.2 Global Finasteride Value by Regions
      • 4.2 Americas Finasteride Consumption Growth
      • 4.3 APAC Finasteride Consumption Growth
      • 4.4 Europe Finasteride Consumption Growth
      • 4.5 Middle East & Africa Finasteride Consumption Growth

      5 Americas

      • 5.1 Americas Finasteride Consumption by Countries
        • 5.1.1 Americas Finasteride Consumption by Countries (2014-2019)
        • 5.1.2 Americas Finasteride Value by Countries (2014-2019)
      • 5.2 Americas Finasteride Consumption by Type
      • 5.3 Americas Finasteride Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Finasteride Consumption by Countries
        • 6.1.1 APAC Finasteride Consumption by Countries (2014-2019)
        • 6.1.2 APAC Finasteride Value by Countries (2014-2019)
      • 6.2 APAC Finasteride Consumption by Type
      • 6.3 APAC Finasteride Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Finasteride by Countries
        • 7.1.1 Europe Finasteride Consumption by Countries (2014-2019)
        • 7.1.2 Europe Finasteride Value by Countries (2014-2019)
      • 7.2 Europe Finasteride Consumption by Type
      • 7.3 Europe Finasteride Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Finasteride by Countries
        • 8.1.1 Middle East & Africa Finasteride Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Finasteride Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Finasteride Consumption by Type
      • 8.3 Middle East & Africa Finasteride Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Finasteride Distributors
      • 10.3 Finasteride Customer

      11 Global Finasteride Market Forecast

      • 11.1 Global Finasteride Consumption Forecast (2019-2024)
      • 11.2 Global Finasteride Forecast by Regions
        • 11.2.1 Global Finasteride Forecast by Regions (2019-2024)
        • 11.2.2 Global Finasteride Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Finasteride Forecast by Type
      • 11.8 Global Finasteride Forecast by Application

      12 Key Players Analysis

      • 12.1 Merck
        • 12.1.1 Company Details
        • 12.1.2 Finasteride Product Offered
        • 12.1.3 Merck Finasteride Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Merck News
      • 12.2 Actavis
        • 12.2.1 Company Details
        • 12.2.2 Finasteride Product Offered
        • 12.2.3 Actavis Finasteride Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Actavis News
      • 12.3 Sandoz
        • 12.3.1 Company Details
        • 12.3.2 Finasteride Product Offered
        • 12.3.3 Sandoz Finasteride Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Sandoz News
      • 12.4 Teva Pharmaceuticals
        • 12.4.1 Company Details
        • 12.4.2 Finasteride Product Offered
        • 12.4.3 Teva Pharmaceuticals Finasteride Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Teva Pharmaceuticals News
      • 12.5 Cipla
        • 12.5.1 Company Details
        • 12.5.2 Finasteride Product Offered
        • 12.5.3 Cipla Finasteride Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Cipla News
      • 12.6 RelonChem
        • 12.6.1 Company Details
        • 12.6.2 Finasteride Product Offered
        • 12.6.3 RelonChem Finasteride Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 RelonChem News
      • 12.7 Dr. Reddy
        • 12.7.1 Company Details
        • 12.7.2 Finasteride Product Offered
        • 12.7.3 Dr. Reddy Finasteride Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Dr. Reddy News
      • 12.8 Accord Pharmaceuticals
        • 12.8.1 Company Details
        • 12.8.2 Finasteride Product Offered
        • 12.8.3 Accord Pharmaceuticals Finasteride Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Accord Pharmaceuticals News
      • 12.9 Henan Topfond
        • 12.9.1 Company Details
        • 12.9.2 Finasteride Product Offered
        • 12.9.3 Henan Topfond Finasteride Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Henan Topfond News
      • 12.10 Zhejiang CONBA Pharmaceutical
        • 12.10.1 Company Details
        • 12.10.2 Finasteride Product Offered
        • 12.10.3 Zhejiang CONBA Pharmaceutical Finasteride Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Zhejiang CONBA Pharmaceutical News
      • 12.11 Shandong Renhetang Pharmaceutical
      • 12.12 Guangdong Eashu Pharmacetical

      13 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on Finasteride . Industry analysis & Market Report on Finasteride is a syndicated market report, published as Global Finasteride Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Finasteride market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,660.00
      $5,490.00
      $7,320.00
      2,840.16
      4,260.24
      5,680.32
      3,411.12
      5,116.68
      6,822.24
      564,701.40
      847,052.10
      1,129,402.80
      308,611.20
      462,916.80
      617,222.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report